Cargando…
Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
This cross-sectional study examines authorization and delivery of COVID-19 vaccines recommended by the World Health Organization in the countries where they were tested.
Autores principales: | Ramachandran, Reshma, Ross, Joseph S., Miller, Jennifer E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603077/ https://www.ncbi.nlm.nih.gov/pubmed/34792596 http://dx.doi.org/10.1001/jamanetworkopen.2021.34233 |
Ejemplares similares
-
Inspiring academia in low- and middle-income countries
por: Vacek, Adam, et al.
Publicado: (2023) -
COVID-19 booster vaccination has not decreased access for low-income countries
por: Kalmar, C.L., et al.
Publicado: (2022) -
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
por: Miller, Jennifer E., et al.
Publicado: (2021) -
Improving access to affordable vaccines for middle-income countries in the african region
por: Mihigo, Richard, et al.
Publicado: (2019) -
Is home pulse oximeter monitoring for COVID-19 feasible in low-income and low-middle-income countries?
por: Rijal, Sabina, et al.
Publicado: (2021)